Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

RANDERS NY DYREHOSPITAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.4% 1.7% 1.1% 2.0% 7.6% 2.7% 14.5% 14.5%   Credit score (0-100)   65 75 84 67 31 59 15 15   Credit rating   BBB A A A BB BBB BB BB   Credit limit (kDKK)   0.0 3.0 124.2 0.3 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,240 4,379 4,783 5,632 5,229 6,315 0.0 0.0   EBITDA   868 599 924 413 -264 373 0.0 0.0   EBIT   793 479 819 304 -337 274 0.0 0.0   Pre-tax profit (PTP)   783.4 447.6 824.5 319.6 -319.5 280.5 0.0 0.0   Net earnings   610.8 347.6 641.9 248.2 -295.9 280.5 0.0 0.0   Pre-tax profit without non-rec. items   783 448 824 320 -319 281 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   467 422 344 376 378 454 0.0 0.0   Shareholders equity total   819 867 1,509 1,157 651 931 581 581   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,994 1,772 3,287 2,598 3,221 2,261 581 581   Net Debt   -997 -765 -1,219 -261 -907 -184 -581 -581     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,240 4,379 4,783 5,632 5,229 6,315 0.0 0.0   Gross profit growth   9.3% 3.3% 9.2% 17.7% -7.1% 20.8% -100.0% 0.0%   Employees   22 24 9 13 12 14 0 0   Employee growth %   -8.3% 9.1% -62.5% 44.4% -7.7% 16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,994 1,772 3,287 2,598 3,221 2,261 581 581   Balance sheet change%   65.2% -11.1% 85.5% -21.0% 24.0% -29.8% -74.3% 0.0%   Added value   867.6 599.4 923.9 413.2 -227.8 372.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   149 -186 -183 -77 -72 -23 -454 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   18.7% 10.9% 17.1% 5.4% -6.5% 4.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   49.9% 25.7% 33.3% 11.2% -10.7% 10.7% 0.0% 0.0%   ROI %   128.3% 55.3% 69.4% 24.4% -33.9% 37.2% 0.0% 0.0%   ROE %   118.9% 41.2% 54.1% 18.6% -32.7% 35.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   41.1% 48.9% 45.9% 44.5% 20.2% 41.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -115.0% -127.6% -132.0% -63.2% 343.5% -49.4% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   19.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 1.1 0.8 0.3 0.4 0.2 0.0 0.0   Current Ratio   1.3 1.4 1.0 0.7 0.6 0.6 0.0 0.0   Cash and cash equivalent   997.3 764.8 1,219.2 261.1 906.6 184.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   364.7 364.7 -10.0 -455.4 -981.9 -496.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   39 25 103 32 -19 27 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   39 25 103 32 -22 27 0 0   EBIT / employee   36 20 91 23 -28 20 0 0   Net earnings / employee   28 14 71 19 -25 20 0 0